Gender & Health

Under pressure from regulators and competitors, Tyson Foods Inc. withdrew its antibiotic-free chicken label awarded by the Agriculture Department barely a year ago. Read More

Energy Secretary Samuel Bodman said Tuesday he's confident the government's license application to build a nuclear waste dump in Nevada will "stand up to any challenge anywhere." Read More

The world's biggest oil company emerged bruised but victorious from a bust-up with the billionaire Rockefeller family yesterday as an effort to foist green initiatives on ExxonMobil failed to capture wholehearted support from shareholders. Read More

Pharmacy-benefits manager Express Scripts Inc. agreed Tuesday to pay $9.5 million to settle allegations that the company asked doctors to switch drugs primarily to get bigger rebates from pharmaceutical companies. Read More

Agriculture Secretary Ed Schafer announced Tuesday a total ban on meat plant slaughter of cows too sick or weak to stand. Read More

Residents of the town of Blackwell, Oklahoma have brought a class action lawsuit against mining giant Freeport McMoRan. The plaintiffs say that the company's zinc smelter, which closed in 1974, left a toxic legacy in the town, including contaminated sand from the smelter that was given away for free. Read More

Four Nigerian villagers and the environmental group Friends of the Earth are demanding Shell take responsibility for damage from oil leaks caused by its Nigerian subsidiary, lawyers said Wednesday. Read More

Residents took to the streets of Chengdu to protest a $5.5 billion ethylene plant under construction by PetroChina, reflecting a surge in environmental awareness by urban, middle-class Chinese determined to protect their health and the value of their property. Read More

A bauxite mine and a proposed refinery in northern Queensland, Australia, to be developed by a Chinese mineral company, has divided local and traditional landowners. Part of a major industrialization scheme, it has also sparked worries among environmentalists. Read More

The Bush administration has argued strongly in favor of the doctrine, which holds that the F.D.A. is the only agency with enough expertise to regulate drug makers and that its decisions should not be second-guessed by courts. The Supreme Court is to rule on a case next term that could make pre-emption a legal standard for drug cases. The court already ruled in February that many suits against the makers of medical devices like pacemakers are pre-empted. Read More